OCT News and Research

RSS

Survey highlights gaps in the UK public's awareness of childhood cancer signs and symptoms

There are significant gaps in the UK public's awareness of the tell-tale signs and symptoms of cancer in children and teens, with just a third of adults expressing confidence in being able to recognize them, find the results of a nationally representative survey published online in the journal Archives of Disease in Childhood.

16 Oct 2023

Study sheds light on early life risk factors for ankylosing spondylitis

Having older siblings and childhood tonsil removal are linked to a heightened risk of ankylosing spondylitis, a type of chronic inflammatory arthritis, finds a large study published in the open access journal RMD Open.

16 Oct 2023

Immersive VR interventions effective in reducing pain and distress among cancer patients

Immersive virtual reality - digital technology that allows a person to experience being physically present in a non-physical world - seems to ease the pain and distress felt by patients with cancer, suggests a pooled data analysis of the available evidence published in BMJ Supportive & Palliative Care.

16 Oct 2023

ChatGPT outperforms doctors in following clinical guidelines for depression treatment

ChatGPT, the AI language model capable of mirroring human conversation, may be better than a doctor at following recognized treatment standards for clinical depression, and without any of the gender or social class biases sometimes seen in the primary care doctor-patient relationship, finds research published in the open access journal Family Medicine and Community Health.

16 Oct 2023

Antibiotic-resistant bacteria in Ghana confined to clinical settings

Calland, J. K., et al. (2023). Population structure and antimicrobial resistance among Klebsiella isolates sampled from human, animal, and environmental sources in Ghana: a cross-sectional genomic One Health study. The Lancet Microbe. doi.org/10.1016/S2666-5247(23)00208-2.

16 Oct 2023

Widely available prescription drug can improve IBS symptoms

A cheap and widely available prescription drug can improve symptoms of irritable bowel syndrome in patients seen in GP surgeries, new research presented today at UEG Week 2023 has found.

16 Oct 2023

Mortality rates during the pandemic significantly reduced in high-performance ICUs

A new study published by CHEST Science Journal shows that high-performance intensive care units (ICUs) might also have better patient outcomes during health crises.

16 Oct 2023

Paxlovid treatment provides protection against COVID-19 for both mother and child

A new mouse model of infection with the COVID-19-causing SARS-CoV-2 virus during pregnancy tracks closely the disease course doctors have observed in SARS-CoV-2-infected pregnant patients, and suggests that treatment with the antiviral Paxlovid provides protection for both mother and child.

16 Oct 2023

Genomic revolution may not be necessary for all species conservation efforts

In the world of threatened and endangered species conservation, the genomic revolution has raised some complicated questions: How can scientists justify assessing species genetic diversity without consulting entire genomes now that they can be sequenced?

16 Oct 2023

Study highlights role of circadian clock component BMAL1 on molecular phenotype of senescent cells

A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 19, entitled, "BMAL1 modulates senescence programming via AP-1."

16 Oct 2023

Researchers discover nuanced insights from COVID-19's impact on mortality rates

A multi-institutional team of researchers led by the White River Junction VA, and including the West Haven and Palo Alto VA, analyzed electronic health record data from more than 5.9 million Veterans-spanning both pre-pandemic (March 2018 - February 2020) and pandemic (March 2020 - February 2022) periods-to discover nuanced insights from COVID-19's impact on mortality rates.

16 Oct 2023

Insilico Medicine to present scientific data on novel anti-cancer assets at major cancer conferences

Clinical stage artificial intelligence (AI) drug discovery company Insilico Medicine ("Insilico") has been invited to present scientific data on its novel anti-cancer assets at three major upcoming cancer conferences -- the European Society for Medical Oncology (ESMO) conference in Madrid Oct. 20-24, 2023; the Society of Immunotherapy of Cancer (SITC) conference Nov. 1-5, 2023 in San Diego; and the San Antonio Breast Cancer Symposium (SABCS) Dec. 5-9, 2023.

16 Oct 2023

Study links long COVID to gut inflammation and serotonin deficiency

Patients with long COVID – the long-term symptoms like brain fog, fatigue, or memory loss in the months or years following COVID-19 – can exhibit a reduction in circulating levels of the neurotransmitter serotonin, according to new research published today in Cell.

16 Oct 2023

Study shows outsized toll of dementia on family caregivers and finances

Most people think of dementia as something that affects a person's brain. But a new study shows just how much damage it does to a person's wallet and bank account too – as well as the higher demands it places on their family members.

16 Oct 2023

Study reveals previously unappreciated role for innate immune cells in early stages of TB infection

A new study from the University of Pittsburgh Center for Vaccine Research published today in the Journal of Experimental Medicine describes a previously unappreciated role for a class of immune cells in the early stages of tuberculosis (TB) infection.

16 Oct 2023

Two 'big gun' antibiotics may be safer for the kidneys than previously thought

Two 'big gun' antibiotics thought to cause kidney failure in ICU patients with a severe bacterial infection, especially when combined with another antibiotic, may be safer for the kidneys than previously reported, following a randomized trial led by Vanderbilt University Medical Center.

16 Oct 2023

Study highlights need for early intervention for behavioral problems

A six-year study that analyzed data from a 25-question screening tool found alarming evidence of unhealthy behavioral trajectories starting as early as age 2 among families affected by low income and other social stressors.

16 Oct 2023

Moffitt Cancer Center researchers identify hidden target of ROS1 inhibitor lorlatinib

Targeted cancer drugs are widely used because of their ability to inhibit specific proteins involved in cancer development with fewer side effects compared to chemotherapy drugs.

16 Oct 2023

Live vaccinations found to be safe for pediatric organ transplant recipients

Live vaccinations provided to children who previously received liver or kidney transplants were found to be safe and prompted an immune response to guard against several life-threatening conditions, according to a new study published Oct. 12, 2023, in JAMA Network Open.

16 Oct 2023

Medicare enrollees can switch coverage now. Here’s what’s new and what to consider.

Consumers know it's fall when stores start offering Halloween candy and flu shots — and airwaves and mailboxes are filled with advertisements for Medicare options.

16 Oct 2023

OCT News and Research

Survey highlights gaps in the UK public's awareness of childhood cancer signs and symptoms

Study sheds light on early life risk factors for ankylosing spondylitis

Immersive VR interventions effective in reducing pain and distress among cancer patients

ChatGPT outperforms doctors in following clinical guidelines for depression treatment

Antibiotic-resistant bacteria in Ghana confined to clinical settings

Widely available prescription drug can improve IBS symptoms

Mortality rates during the pandemic significantly reduced in high-performance ICUs

Paxlovid treatment provides protection against COVID-19 for both mother and child

Genomic revolution may not be necessary for all species conservation efforts

Study highlights role of circadian clock component BMAL1 on molecular phenotype of senescent cells

Researchers discover nuanced insights from COVID-19's impact on mortality rates

Insilico Medicine to present scientific data on novel anti-cancer assets at major cancer conferences

Study links long COVID to gut inflammation and serotonin deficiency

Study shows outsized toll of dementia on family caregivers and finances

Study reveals previously unappreciated role for innate immune cells in early stages of TB infection

Two 'big gun' antibiotics may be safer for the kidneys than previously thought

Study highlights need for early intervention for behavioral problems

Moffitt Cancer Center researchers identify hidden target of ROS1 inhibitor lorlatinib

Live vaccinations found to be safe for pediatric organ transplant recipients

Medicare enrollees can switch coverage now. Here’s what’s new and what to consider.

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News